Eisai, Biogen launch subcutaneous Leqembi autoinjector in the U.S.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 240.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.98 | 52 Week High | $333.65 | |||
| Open | $240.98 | 52 Week Low | $223.02 | |||
| Day High | $240.98 | P/E | 30.86 | |||
| Day Low | $240.98 | EPS | $7.81 | |||
| Volume | 649 | |||||
